Cargando…

Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress

Many now believe the holy grail for the next stage of therapeutic advance surrounds the development of disease-modifying approaches aimed at intercepting the year-on-year neurodegenerative decline experienced by most patients with Parkinson’s disease (PD). Based on recommendations of an internationa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carroll, Camille B., Wyse, Richard K.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676977/ https://www.ncbi.nlm.nih.gov/pubmed/29036837 http://dx.doi.org/10.3233/JPD-171203

Ejemplares similares

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial
por: Stevens, Kara N., et al.
Publicado: (2022)

Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study
por: Carroll, Camille B, et al.
Publicado: (2019)

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020
por: McFarthing, Kevin, et al.
Publicado: (2020)

Treatment of experimental periodontal disease by laser therapy in simvastatin-modified rats
por: SWERTS, Andressa Araújo, et al.
Publicado: (2017)

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
por: McFarthing, Kevin, et al.
Publicado: (2021)

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update
por: McFarthing, Kevin, et al.
Publicado: (2022)

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
por: Wolozin, Benjamin, et al.
Publicado: (2007)

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
por: McFarthing, Kevin, et al.
Publicado: (2023)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
por: Stott, Simon R. W., et al.
Publicado: (2021)

Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol
por: Janssen Daalen, Jules M., et al.
Publicado: (2022)

The Rationale for Exercise in the Management of Pain in Parkinson’s Disease
por: Allen, Natalie E., et al.
Publicado: (2015)

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
por: Foltynie, Tom, et al.
Publicado: (2023)

Simvastatin in the Prevention of Recurrent Pancreatitis: Design and Rationale of a Multicenter Triple-Blind Randomized Controlled Trial, the SIMBA Trial
por: Cárdenas-Jaén, Karina, et al.
Publicado: (2021)

Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
por: Kones, Richard
Publicado: (2010)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
por: Lauterbach, Edward C., et al.
Publicado: (2012)

Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
por: Maraganore, Demetrius M.
Publicado: (2011)

Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
por: Prasad, E. Maruthi, et al.
Publicado: (2021)

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
por: Rotella, Carlo M, et al.
Publicado: (2010)

Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative
por: Gonzalez-Robles, Cristina, et al.
Publicado: (2023)

Two-arm randomised futility trials: PD-stat - a futility trial of a potential neuroprotective treatment in people with Parkinson's disease
por: Creanor, Siobhan, et al.
Publicado: (2015)

The current status of gene therapy for Parkinson's disease
por: Muramatsu, Shin-ichi
Publicado: (2010)

Genome-wide Analysis of Motor Progression in Parkinson Disease
por: Martínez Carrasco, Alejandro, et al.
Publicado: (2023)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
por: Fields, Carroll Rutherford, et al.
Publicado: (2019)

Antioxidant Therapy in Cancer: Rationale and Progress
por: Luo, Maochao, et al.
Publicado: (2022)

Repurposing Simvastatin in Parkinson’s Disease Model: Protection Is throughout Modulation of the Neuro-Inflammatory Response in the Substantia nigra
por: Rubio-Osornio, Moisés, et al.
Publicado: (2023)

Linked Clinical Trials – The Development of New Clinical Learning Studies in Parkinson’s Disease Using Screening of Multiple Prospective New Treatments
por: Brundin, Patrik, et al.
Publicado: (2013)

Genetic networks in Parkinson’s and Alzheimer’s disease
por: Kelly, Jack, et al.
Publicado: (2020)

The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers
por: Paolini Paoletti, Federico, et al.
Publicado: (2020)

Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics
por: Han, Myat Noe, et al.
Publicado: (2022)

The Rationale for Insulin Therapy in Alzheimer’s Disease
por: Ribarič, Samo
Publicado: (2016)

Current Immunotherapies for Sarcoma: Clinical Trials and Rationale
por: Mitsis, Demytra, et al.
Publicado: (2016)

People with Parkinson's design clinical trials charter to improve communication about, recruitment to and retention in Parkinson's clinical trials
por: Stamford, Jon, et al.
Publicado: (2015)

Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation
por: Magrinelli, Francesca, et al.
Publicado: (2016)

Is there a Neurobiological Rationale for the Utility of the Iowa Gambling Task in Parkinson’s Disease?
por: Salvatore, Michael F., et al.
Publicado: (2021)

A Placebo-Controlled Trial of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
por: Wassif, Christopher A., et al.
Publicado: (2016)

Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease
por: Dong, Jie, et al.
Publicado: (2016)

Current Experimental Studies of Gene Therapy in Parkinson's Disease
por: Lin, Jing-ya, et al.
Publicado: (2017)

Current Treatments and New, Tentative Therapies for Parkinson’s Disease
por: Pardo-Moreno, Teresa, et al.
Publicado: (2023)

Current and novel infusion therapies for patients with Parkinson's disease
por: Antonini, Angelo, et al.
Publicado: (2023)

Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT
por: Kehagia, Angie A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0h252h28k9hnlj224bceb46429